22157.jpg
Revolutionizing the Future of Medicine: Cell Therapy Technologies Market Set to Surpass US$ 7.04 Billion in 2024
June 06, 2024 04:03 ET | Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.World revenue for the Cell Therapy...
Global CAR T Cell Therapy Market
CAR T Cell Therapy Market Industry Trends and Global Forecasts to 2035: Rising Leukemia and Lymphoma Cases Boost CAR T Cell Therapy Market, with Positive Phase III Trials Expanding Treatment Potential
June 05, 2024 08:03 ET | Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "CAR T Cell Therapy Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Indication, Target Antigens, Key Geographical...
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
June 04, 2024 16:05 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
Wael-Photo-1
Longeveron® Announces Contract Development and Manufacturing Business and First Contract
June 03, 2024 09:00 ET | Longeveron
Longeveron launches contract development and manufacturing business for stem cell therapies. 15,000 sf state-of-the-art GMP facility with 8 cleanrooms.
22157.jpg
Analysis of the Allogenic iNKT Cell Therapy Pipeline, 2024: Emerging Therapies, Products, Leading Companies, Unmet Needs, and More
May 31, 2024 06:07 ET | Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Allogenic iNKT Cell Therapy - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.Allogenic iNKT Cell Therapy...
Longeveron Logo.jpg
Longeveron® to Attend BIO International Convention 2024
May 28, 2024 08:05 ET | Longeveron
Longeveron to attend BIO 2024, exploring potential partnership and strategic opportunities for its Alzheimer’s disease program.
Logo_Horizontal_Fill_White_Transparent.png
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
May 28, 2024 08:00 ET | Neurona Therapeutics
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
May 28, 2024 08:00 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
22157.jpg
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market to Surge to US$ 11.28 Billion by 2034, Propelled by Tranformative Cancer Treatments
May 27, 2024 09:43 ET | Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Chimeric Antigen Receptor (CAR) T-Cell Therapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report...
NHRA Logo - Orginal 250.png
Bahrain Oncology Centre Amongst the First in the World to Offer Ground-breaking Sickle Cell and Transfusion Dependent Thalassemia Gene Therapy
May 22, 2024 15:18 ET | National Health Regulatory Authority
MUHARRAQ, Bahrain, May 22, 2024 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has achieved a significant milestone, becoming amongst the first centres in the World to offer the...